671 related articles for article (PubMed ID: 18330082)
1. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
2. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
3. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
4. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
[TBL] [Abstract][Full Text] [Related]
5. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
6. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
7. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
8. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
9. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
10. Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Prenat Diagn; 1996 Jul; 16(7):635-9. PubMed ID: 8843473
[TBL] [Abstract][Full Text] [Related]
11. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
12. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
Burton BK
Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
[TBL] [Abstract][Full Text] [Related]
13. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
14. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
Killam WP; Miller RC; Seeds JW
Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
[TBL] [Abstract][Full Text] [Related]
15. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
16. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
19. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
[TBL] [Abstract][Full Text] [Related]
20. Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome.
Kiran TS; Bethel J; Bhal PS
J Obstet Gynaecol; 2005 Apr; 25(3):253-6. PubMed ID: 16147728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
